Literature DB >> 9495672

Rapid increase in the prevalence of antimicrobial drug resistance among enterococcal blood isolates in southern Israel.

N Marcus1, N Peled, P Yagupsky.   

Abstract

A prospective surveillance was conducted to monitor the prevalence and dynamics of antimicrobial resistance among enterococci isolated from blood cultures in southern Israel. A total of 242 organisms isolated between 1993 and 1996 were studied. The prevalence of Enterococcus faecalis significantly decreased during the study period, whereas that of Enterococcus faecium doubled. Antimicrobial drug resistance increased steadily among Enterococcus faecium isolates: resistance to ampicillin increased from 19% in 1993-1994 to 53% in 1995, and to 67% in 1996 (p = 0.005); during the same period, resistance to vancomycin increased from 0% to 20%, and to 50% (p = 0.002), and combined resistance to ampicillin and vancomycin and high-level resistance to gentamicin from 0% to 20% and to 38% (p < 0.02).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9495672     DOI: 10.1007/BF01700558

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  10 in total

1.  Vancomycin-resistant enterococcus faecium: headline news.

Authors:  D A Goldmann
Journal:  Infect Control Hosp Epidemiol       Date:  1992-12       Impact factor: 3.254

Review 2.  Emergence of Enterococcus as a significant pathogen.

Authors:  R C Moellering
Journal:  Clin Infect Dis       Date:  1992-06       Impact factor: 9.079

3.  The E-Test applied to susceptibility tests of gonococci, multiply-resistant enterococci, and Enterobacteriaceae producing potent beta-lactamases.

Authors:  M L Sanchez; M S Barrett; R N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  1992-07       Impact factor: 2.803

Review 4.  Antimicrobial resistance among enterococci.

Authors:  D J Herman; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

5.  Multiply-resistant Enterococcus faecium. The nosocomial pathogen of the 1990s.

Authors:  R V Spera; B F Farber
Journal:  JAMA       Date:  1992-11-11       Impact factor: 56.272

Review 6.  Epidemiology and control of multiresistant enterococci.

Authors:  R Leclercq
Journal:  Drugs       Date:  1996       Impact factor: 9.546

Review 7.  Enterococci acquire new kinds of resistance.

Authors:  R Leclercq
Journal:  Clin Infect Dis       Date:  1997-01       Impact factor: 9.079

Review 8.  The enterococcus: "putting the bug in our ears".

Authors:  S A Hoffmann; R C Moellering
Journal:  Ann Intern Med       Date:  1987-05       Impact factor: 25.391

Review 9.  Enterococcus, an emerging pathogen.

Authors:  S A Tailor; E M Bailey; M J Rybak
Journal:  Ann Pharmacother       Date:  1993-10       Impact factor: 3.154

Review 10.  Vancomycin resistance in the enterococcus. Relevance in pediatrics.

Authors:  L B Rice; D M Shlaes
Journal:  Pediatr Clin North Am       Date:  1995-06       Impact factor: 3.278

  10 in total
  1 in total

1.  Epidemiology of glycopeptide-resistant enterococci colonizing high-risk patients in hospitals in Johannesburg, Republic of South Africa.

Authors:  A von Gottberg; W van Nierop; A Dusé; M Kassel; K McCarthy; A Brink; M Meyers; R Smego; H Koornhof
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.